Showing 3951-3960 of 23227 results for "".
Equitable Care for ATTR-CM: Improving Early Diagnosis in High-Risk Groups
https://reachmd.com/programs/heart-matters/equitable-care-for-attr-cm-improving-early-diagnosis-in-high-risk-groups/36142/Early detection of transthyretin amyloid cardiomyopathy (ATTR-CM), particularly in high-risk populations, requires a multifaceted approach that combines community-based interventions, collaboration across specialties, and technological integration. Join Dr. Kevin Alexander, an Assistant Professor ofAnalyzing a Mobile App’s Impacts on COVID-19 Vaccine Trust in Young Black Adults
https://reachmd.com/programs/clinicians-roundtable/analyzing-a-mobile-apps-impacts-on-covid-19-vaccine-trust-in-young-black-adults/36411/Integrating Physical Activity into COPD Care: From Education to Exercise-Based Interventions
https://reachmd.com/programs/frontlines-copd/integrating-physical-activity-into-copd-care-from-education-to-exercise-based-interventions/35857/Physical activity is foundational to COPD management, but many patients struggle to stay active due to symptoms like dyspnea. Dr. Patricia Bamonti joins us to explore how promoting movement, teaching pacing and breathing techniques, and addressing motivational barriers can help patients break the cyManaging Acne in Pregnancy: A Review of First- and Second-Line Treatments
https://reachmd.com/programs/clinicians-roundtable/managing-acne-in-pregnancy-a-review-of-first-and-second-line-treatments/30054/Since acne is one of the most common conditions that dermatologists see in pregnant patients, it’s important to be aware of the available first- and second-line treatments as well as their associated considerations for this patient population. Here to share best practices for managing acne in pregnaBreakthroughs in Alopecia Areata Treatment
https://reachmd.com/conferences/masterclasses-in-dermatology-2025/breakthroughs-in-alopecia-areata-treatment/33019/Adelaide A. Hebert, MD, chief of pediatric dermatology at the University of Texas Medical School in Houston, talks about her presentation at Masterclasses in Dermatology 2025 discusses breatkthrough treatments for alopecia areata in patients aged 12 and older.Acne and Rosacea: Dr. Harper
https://reachmd.com/programs/practical-dermatology/acne-and-rosacea-dr-harper/32686/Julie Harper, MD, summarizes her presentation during the "Update 2025: Acne and Rosacea" session at Maui Derm 2025, which focused on spironolactone, oral contraceptives, and topical clascoterone.Diving into the Efficacy & Tolerability of mBC Treatment
https://reachmd.com/programs/project-oncology/diving-into-the-efficacy-tolerability-of-mbc-treatment/15818/An oral chemotherapy drug is preferred by physicians and patients for mBC patients. However, the current approved dosing has cumulative toxicity.Properly Diagnosing & Treating C. Difficile
https://reachmd.com/programs/gi-insights/properly-diagnosing-treating-c-difficile/14239/Is there concern among clinicians about potentially over-diagnosing patients with C. difficile? Find out.Challenging Common Misconceptions About Vitiligo
https://reachmd.com/programs/dermconsult/challenging-common-misconceptions-about-vitiligo/13973/While our understanding of vitiligo has come a long way, there are still many misconceptions about this disease. What do we need to know about them?Expert Perspectives on Anti-TNF Therapy in the Perioperative Period
https://reachmd.com/programs/gi-insights/expert-perspectives-on-anti-tnf-therapy-in-the-perioperative-period/13952/Emerging clinical trial data from the PUCCINI study may offer some new evidence on anti-TNF therapy. What does that mean for our patients with IBD?